Paclitaxel and carboplatin followed by concomitant paclitaxel, cisplatin, and radiotherapy for inoperable stage III non-small cell lung cancer

被引：0
|
作者：
Mattson, K
Isokangas, OP
Halme, M
Joensuu, H
机构：
[1] Univ Helsinki, Cent Hosp, Dept Internal Med, Div Pulm, Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Dept Oncol, Helsinki, Finland
来源：
SEMINARS IN ONCOLOGY | 1999年 / 26卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：72 / 72
页数：1
相关论文
共 50 条
  • [1] Paclitaxel (Taxol®) and carboplatin followed by concomitant paclitaxel, cisplatin and radiotherapy for inoperable stage III NSCLC
    Isokangas, OP
    Joensuu, H
    Halme, M
    Jekunen, A
    Mattson, K
    LUNG CANCER, 1998, 20 (02) : 127 - 133
  • [2] Concurrent chemoradiotherapy (CCRT) with paclitaxel followed by paclitaxel and carboplatin consolidation in patients with inoperable stage III non-small cell lung cancer (NSCLC)
    Bae, S. H.
    Ryoo, H. M.
    Kim, K. C.
    Hyun, D. -S.
    Lee, S. -C.
    Yei, J. W.
    Jung, K. -J.
    Bae, J. Y.
    LUNG CANCER, 2006, 52 : S41 - S41
  • [3] Concurrent chemoradiotherapy (CCRT) with paclitaxel followed by paclitaxel and carboplatin consolidation in patients with inoperable stage III non-small cell lung cancer (NSCLC)
    Bae, S
    Ryoo, H
    Kim, K
    Hyun, D
    Lee, S
    Yei, J
    Bae, J
    Yun, S
    Lee, K
    Hyun, M
    LUNG CANCER, 2005, 49 : S165 - S166
  • [4] Weekly paclitaxel and carboplatin chemotherapy with concomitant radiotherapy in locally advanced inoperable non-small cell lung cancer (NSCLC)
    Spasova, Irena
    Pajdhauser, Roman
    Skacel, Zdenek
    Marel, Miloslav
    Musil, Jaromir
    CHEST, 2006, 130 (04) : 233S - 233S
  • [5] Concurrent radiochemotherapy with carboplatin and paclitaxel followed by consolidation chemotherapy in patients with inoperable stage III non-small cell lung cancer (NSCLC)
    Serdar, Ozkok
    Dubova, S.
    Guersel, C.
    Yalman, D.
    T Goeksel
    Goker, E.
    LUNG CANCER, 2006, 52 : S41 - S41
  • [6] COMPARISON OF TOXICITY AND OUTCOMES OF CONCURRENT RADIOTHERAPY WITH CARBOPLATIN/PACLITAXEL AND CISPLATIN/ETOPOSIDE IN STAGE III NON-SMALL CELL LUNG CANCER
    Liew, Mun Sem
    Sia, Joseph
    Starmans, Maud H. W.
    Tafreshi, Ali
    Harris, Sam
    Feigen, Malcolm
    White, Shane
    Zimet, Allan
    Lambin, Philippe
    Boutros, Paul
    Mitchell, Paul
    John, Thomas
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S851 - S852
  • [7] Comparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel or cisplatin/etoposide in stage III non-small cell lung cancer
    Liew, Mun Sem
    Sia, Joseph
    Starmans, Maud H. W.
    Tafreshi, Ali
    Harris, Sam
    Feigen, Malcolm
    White, Shane
    Zimet, Allan
    Lambin, Philippe
    Boutros, Paul C.
    Mitchell, Paul
    John, Thomas
    CANCER MEDICINE, 2013, 2 (06): : 916 - 924
  • [8] Weekly carboplatin, twice-weekly paclitaxel, and thoracic radiation followed by carboplatin/paclitaxel for stage III non-small cell lung cancer: An interim analysis
    Lau, D
    Leigh, B
    Gandara, D
    Edelman, M
    Morgan, R
    Wilder, R
    Doroshow, J
    Ryu, J
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 70 - 70
  • [9] Retrospective review of stage III non-small cell lung cancer (NSCLC) patients treated with carboplatin/paclitaxel plus radiotherapy followed by docetaxel
    Patel, M. R.
    Weidner, M.
    Lynch, J. W., Jr.
    Walden, E.
    George, T. J., Jr.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Phase I trial of carboplatin/paclitaxel/bortezomib and concurrent radiotherapy followed by surgical resection in Stage III non-small cell lung cancer
    Edelman, Martin J.
    Burrows, Whitney
    Krasna, Mark J.
    Bedor, Michelle
    Smith, Ruth
    Suntharalingam, Mohan
    LUNG CANCER, 2010, 68 (01) : 84 - 88
12345